Identification and structure-activity relationship (SAR) of chemical constituents from Daemonorops draco (Willd.) Blume and selected commercial flavonoids on anti-osteoclastogenesis activity
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Fitoterapia
- Vol. 138, 104280
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Divergent Resorbability and Effects on Osteoclast Formation of Commonly Used Bone Substitutes in a Human In Vitro-AssayPLOS ONE, 2012
- Inhibitory effect of luteolin on osteoclast differentiation and functionCytotechnology, 2009
- Methyl Ganoderic Acid DM: A Selective Potent Osteoclastogenesis InhibitorThe Open Bioactive Compounds Journal, 2009
- Naringenin inhibits human osteoclastogenesis and osteoclastic bone resorptionJournal of Periodontal Research, 2009
- The generation of osteoclasts from RAW 264.7 precursors in defined, serum-free conditionsJournal of Bone and Mineral Metabolism, 2008
- Baicalein inhibits osteoclast differentiation and induces mature osteoclast apoptosisFood and Chemical Toxicology, 2008
- Dragon's blood: Botany, chemistry and therapeutic usesJournal of Ethnopharmacology, 2008
- Mutagenic and antioxidant activities of Croton lechleri sap in biological systemsJournal of Ethnopharmacology, 2004
- Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NFκB and AP‐1Journal of Cellular Biochemistry, 2004
- Constituents of Dragon's blood. Part I. Structure and absolute configuration of new optically active flavansJournal of the Chemical Society C: Organic, 1971